Inhibiting the phosphatase activity of soluble epoxide hydrolase reduces arterial calcification and prevents the cardiovascular complications of chronic kidney disease

Saved in:
Bibliographic Details
Published in:Fundamental & clinical pharmacology 2022, Vol.36 (1, SI), p.24-25
Main Authors: Messaoudi, H., Varennes, O., Perzo, N., Berg, E., Levesque, T., Duflot, T., Chegrani, G., Kauffenstein, G., Dumesnil, A., Mulder, P., Brunel, V., Six, I., Mentaverri, R., Guerrot, D., Hamzaoui, M., Richard, V., Morisseau, C., Kamel, Saïd, Proschak, E., Bellien, J.
Format: Article
Language:English
Subjects:
Human health and pathology
Life Sciences
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0767-3981
1472-8206